RxDoctor Payments Data

Ameay Naravane, MD

Glaucoma Specialist · Littleton, CONPI 1598385148

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,120 of the $3,301 with a category attached, or 64.2%. 6 manufacturers reported payments, led by AbbVie at 56.9% of the total.

$3,301in general payments, 2019–2025

Across 32 payments — averaging $103.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sight Sciences, Inc.$727
  • NEW World Medical,inc.$336
  • Alcon$182
  • Glaukos Corporation$150
  • Amgen$28

What the payments were for

  • Travel & lodging$1,18136%
  • Food & beverage$2,12064%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie14$1,880
Sight Sciences, Inc.9$727
NEW World Medical,inc.3$336
Alcon3$182
Glaukos Corporation2$150
Amgen1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few glaucoma specialist providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$11,546
Medicare patients
60
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol18$2,171
Prednisolone Acetate69$1,995
Brimonidine Tartrate52$757
Latanoprost101$651
Atropine Sulfate12$491
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat36$488
MoxifloxacinMoxifloxacin Hcl27$430
Dorzolamide Hcl25$294
Timolol Maleate15$47

Paid to pharmacies, not to this prescriber.

Other glaucoma specialist in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →